The statement touches on issues such as the reporting of secondary findings, adult-onset conditions, incest, and non-paternity results.
ImmunArray is launching the SLE-Key Rule Out test to exclude a diagnosis of lupus, a test run on its multiple-antigen microarray-based technology.
Using genome sequencing data on 30 Brazilians and genotyping information on almost 6,500 more, the Brazilian EPIGEN Project Consortium considered ancestry and admixture patterns in three parts of Brazil.
The microarray facilitates drug screening in cancer stem cells and other rare cell populations.
Industry observers believe that Y chromosome sequencing services — until now the domain of advanced genetic genealogists and academics — could become more popular.
In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.
A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.
A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.
The BabySeq project to study the risks and benefits of sequencing newborns is underway.